title: Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever.
authors.forename: Huang Xiao
authors.initials: HX
authors.lastname: Jun
authors.forename: Shen
authors.initials: S
authors.lastname: Zhixiang
authors.forename: Wang
authors.initials: W
authors.lastname: Chun
authors.forename: A Harryanto
authors.initials: AH
authors.lastname: Reksodiputro
authors.forename: Dody
authors.initials: D
authors.lastname: Ranuhardy
authors.forename: Kazuo
authors.initials: K
authors.lastname: Tamura
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Matsumoto
authors.forename: Dong-Gun
authors.initials: DG
authors.lastname: Lee
authors.forename: S Visalachy
authors.initials: SV
authors.lastname: Purushotaman
authors.forename: Victor
authors.initials: V
authors.lastname: Lim
authors.forename: Altaf
authors.initials: A
authors.lastname: Ahmed
authors.forename: Yasser
authors.initials: Y
authors.lastname: Hussain
authors.forename: Manolito
authors.initials: M
authors.lastname: Chua
authors.forename: Adrian
authors.initials: A
authors.lastname: Ong
authors.forename: Cheng-Yi
authors.initials: CY
authors.lastname: Liu
authors.forename: Po-Ren
authors.initials: PR
authors.lastname: Hsueh
authors.forename: Shaeng-Fung
authors.initials: SF
authors.lastname: Lin
authors.forename: Yung-Ching
authors.initials: YC
authors.lastname: Liu
authors.forename: Panpit
authors.initials: P
authors.lastname: Suwangool
authors.forename: Saengsuree
authors.initials: S
authors.lastname: Jootar
authors.forename: Juan J
authors.initials: JJ
authors.lastname: Picazo
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D004359:Drug Therapy, Combination; D005335:Fever of Unknown Origin / Q000150:complications* / Q000188:drug therapy*; D017408:Guidelines as Topic / Q000592:standards*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications* / Q000188:drug therapy*; D012307:Risk Factors; D016896:Treatment Outcome; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000627:therapeutic use; D047090:beta-Lactams / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D065093:beta-Lactamase Inhibitors; D047090:beta-Lactams; D001618:beta-Lactamases